Bleichroeder LP Dia Medica Therapeutics Inc. Transaction History
Bleichroeder LP
- $296 Million
- Q3 2024
A detailed history of Bleichroeder LP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Bleichroeder LP holds 382,317 shares of DMAC stock, worth $2.02 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
382,317
Previous 382,317
-0.0%
Holding current value
$2.02 Million
Previous $1.13 Million
42.06%
% of portfolio
0.54%
Previous 0.41%
Shares
3 transactions
Others Institutions Holding DMAC
# of Institutions
42Shares Held
4.22MCall Options Held
8.2KPut Options Held
200-
Vanguard Group Inc Valley Forge, PA1.05MShares$5.54 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$4.43 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX483KShares$2.55 Million3.74% of portfolio
-
Geode Capital Management, LLC Boston, MA307KShares$1.62 Million0.0% of portfolio
-
Jacob Asset Management Of New York LLC Hermosa Beach, CA169KShares$890,8940.62% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $140M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...